These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22821269)

  • 41. Charting protein complexes, signaling pathways, and networks in the immune system.
    Bauch A; Superti-Furga G
    Immunol Rev; 2006 Apr; 210():187-207. PubMed ID: 16623772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cardiovascular proteomics: challenges and opportunities for cardiologists of the future].
    Banfi C; Brioschi M; Tremoli E
    G Ital Cardiol (Rome); 2013; 14(7-8):495-503. PubMed ID: 23877547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Towards the analysis of protein species: an overview about strategies and methods.
    Jungblut PR; Schlüter H
    Amino Acids; 2011 Jul; 41(2):219-22. PubMed ID: 21243509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteolytic 18O-labeling strategies for quantitative proteomics.
    Miyagi M; Rao KC
    Mass Spectrom Rev; 2007; 26(1):121-36. PubMed ID: 17086517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective on Mycobacterium tuberculosis proteomics.
    Mehaffy MC; Kruh-Garcia NA; Dobos KM
    J Proteome Res; 2012 Jan; 11(1):17-25. PubMed ID: 21988637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Site-Specific Proteomic Mapping Identifies Selectively Modified Regulatory Cysteine Residues in Functionally Distinct Protein Networks.
    Gould NS; Evans P; Martínez-Acedo P; Marino SM; Gladyshev VN; Carroll KS; Ischiropoulos H
    Chem Biol; 2015 Jul; 22(7):965-75. PubMed ID: 26165157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advances in the analysis of dynamic protein complexes by proteomics and data processing.
    Schubert P; Hoffman MD; Sniatynski MJ; Kast J
    Anal Bioanal Chem; 2006 Oct; 386(3):482-93. PubMed ID: 16933131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decoding signalling networks by mass spectrometry-based proteomics.
    Choudhary C; Mann M
    Nat Rev Mol Cell Biol; 2010 Jun; 11(6):427-39. PubMed ID: 20461098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Architecture of the human interactome defines protein communities and disease networks.
    Huttlin EL; Bruckner RJ; Paulo JA; Cannon JR; Ting L; Baltier K; Colby G; Gebreab F; Gygi MP; Parzen H; Szpyt J; Tam S; Zarraga G; Pontano-Vaites L; Swarup S; White AE; Schweppe DK; Rad R; Erickson BK; Obar RA; Guruharsha KG; Li K; Artavanis-Tsakonas S; Gygi SP; Harper JW
    Nature; 2017 May; 545(7655):505-509. PubMed ID: 28514442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of mass spectrometry based proteomics to understand diabetes: A special focus on interactomics.
    Kalita B; Bano S; Vavachan VM; Taunk K; Seshadri V; Rapole S
    Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140469. PubMed ID: 32554214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Next-generation proteomics: towards an integrative view of proteome dynamics.
    Altelaar AF; Munoz J; Heck AJ
    Nat Rev Genet; 2013 Jan; 14(1):35-48. PubMed ID: 23207911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell signalling analyses in the functional genomics era.
    Rogne M; Taskén K
    N Biotechnol; 2013 Mar; 30(3):333-8. PubMed ID: 23369868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PROTEOMICS reviews 2013.
    Dunn MJ
    Proteomics; 2013 Feb; 13(3-4):399-403. PubMed ID: 23417839
    [No Abstract]   [Full Text] [Related]  

  • 54. Key issues in the acquisition and analysis of qualitative and quantitative mass spectrometry data for peptide-centric proteomic experiments.
    Thompson AJ; Abu M; Hanger DP
    Amino Acids; 2012 Sep; 43(3):1075-85. PubMed ID: 22821266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein-protein cross-linking and human health: the challenge of elucidating with mass spectrometry.
    Maes E; Dyer JM; McKerchar HJ; Deb-Choudhury S; Clerens S
    Expert Rev Proteomics; 2017 Oct; 14(10):917-929. PubMed ID: 28759730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of networks of host proteins in the early time points following HIV transduction.
    Csősz É; Tóth F; Mahdi M; Tsaprailis G; Emri M; Tőzsér J
    BMC Bioinformatics; 2019 Jul; 20(1):398. PubMed ID: 31315557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Mass spectrometry-based protein analysis and signaling proteomics].
    Taniguchi H
    Seikagaku; 2004 Oct; 76(10):1289-95. PubMed ID: 15580860
    [No Abstract]   [Full Text] [Related]  

  • 58. Minireview: progress and challenges in proteomics data management, sharing, and integration.
    Becnel LB; McKenna NJ
    Mol Endocrinol; 2012 Oct; 26(10):1660-74. PubMed ID: 22902541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative proteomic analysis of compartmentalized signaling networks.
    Hernandez-Valladares M; Aran V; Prior IA
    Methods Enzymol; 2014; 535():309-25. PubMed ID: 24377931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mapping Cellular Polarity Networks Using Mass Spectrometry-based Strategies.
    Daulat AM; Puvirajesinghe TM; Camoin L; Borg JP
    J Mol Biol; 2018 Sep; 430(19):3545-3564. PubMed ID: 29782831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.